OctaAlpha1
- Generic Name
- OctaAlpha1
Study Comparing Weekly Intravenous Administration of OctaAlpha1 With a Marketed Preparation Glassia® in Subjects With Alpha-1-antitrypsin Deficiency
- First Posted Date
- 2017-12-28
- Last Posted Date
- 2018-04-10
- Lead Sponsor
- Octapharma
- Registration Number
- NCT03385395
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath